4.6 Article

Staging Concordance and Guideline-Concordant Treatment for Esophageal Adenocarcinoma

期刊

ANNALS OF THORACIC SURGERY
卷 113, 期 1, 页码 279-285

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.athoracsur.2020.12.046

关键词

-

资金

  1. Cancer Prevention and Research Institute of Texas [RP160097]
  2. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development
  3. Center for Innovations in Quality, Effectiveness and Safety [CIN 13-413]

向作者/读者索取更多资源

Inaccurate clinical staging information for esophageal adenocarcinoma patients may lead to deviations from treatment guidelines, which should be a new focus for quality improvement efforts.
BACKGROUND Treatment selection for patients with esophageal adenocarcinoma is predicated on clinical staging information, which is inaccurate in 20% to 30% of cases and could impact the delivery of guideline-concordant treatment. We aimed to evaluate the association between staging concordance at the patient and hospital levels with the delivery of guideline-concordant treatment among esophageal adenocarcinoma patients. METHODS This was a national cohort study of resected esophageal adenocarcinoma patients in the National Cancer Data Base (2006 to 2015) treated either with upfront resection or neoadjuvant therapy followed by surgery. Patient-and hospital-level clinical and pathologic staging concordance and deviations from treatment guidelines were ascertained. For neoadjuvant therapy patients, staging concordance was predicted through Bayesian analysis. Reliability adjustment was used when evaluating hospital-level concordance. RESULTS Among 9393 esophageal adenocarcinoma patients treated at 927 hospitals, 41% had upfront surgery. Among upfront surgery patients, staging concordance was 85.1% for T1N0 and 86.9% for T3-T4ND disease, but less than 50% for all others. Among patients treated with neoadjuvant therapy, treatment downstaging was observed in 33.9%. Deviations from treatment guidelines were identified in 38.5% of upfront surgery patients and 3.3% of neo-adjuvant therapy patients. The proportion of concordantly staged patients ranged from 60.1% to 87.9%, and deviations from treatment guidelines were observed among 14.9% to 22.7% of the patients. Patient staging concordance increased, and deviations from guidelines decreased, as hospital-level concordance increased (trend test, P values less than .001 for all). CONCLUSIONS Deviations from treatment guidelines in esophageal adenocarcinoma patients appear to be a function of inaccurate clinical staging information, which should be a new focus for quality improvement efforts. (Ann Thorac Surg 2022;113:279-85) (c) 2022 by The Society of Thoracic Surgeons

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据